Rapid Identification of Candida auris by Raman Spectroscopy Combined With Deep Learning

被引:0
作者
Koya, S. Kiran [1 ]
Brusatori, Michelle A. [1 ]
Yurgelevic, Sally [1 ]
Huang, Changhe [1 ]
Demeulemeester, Jake [1 ]
Percefull, Danielle [1 ]
Salimnia, Hossein [2 ,3 ]
Auner, Gregory W. [1 ,4 ]
机构
[1] Wayne State Univ, Sch Med, Michael & Marian Ilitch Dept Surg, Smart Sensors & Integrated Microsyst Program, Detroit, MI 48202 USA
[2] WAYNE STATE UNIV, Sch Med, Dept Pathol, DETROIT, MI USA
[3] Detroit Med Ctr Univ Labs, Detroit, MI USA
[4] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI 48202 USA
关键词
<fixed-case><italic>Candida auris</italic></fixed-case>; <fixed-case><italic>Candida</italic></fixed-case> species; Raman spectroscopy; rapid diagnostics; CYTOCHROME-C; REDOX STATE; CELL-WALL; IN-VIVO; ALBICANS; ERGOSTEROL; DEATH;
D O I
10.1002/jrs.6763
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Candida auris is a multidrug-resistant yeast that can lead to outbreaks in healthcare facilities, even with strict infection prevention and control measures. Candida auris detection is challenging using standard laboratory methods. Advancements in identification methods, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and polymerase chain reaction, have improved detection, though these methodologies can be costly and impractical in resource-limited settings. This study presents a practical, portable, and reagentless platform known as Counter-Propagating Gaussian Beam Raman Spectroscopy (CPGB-RS), integrated with deep learning spectral analysis for the rapid and accurate identification of C. auris. This method has shown a sensitivity of 96% and a specificity of 99% in differentiating C. auris from other highly prevalent pathogenic species, such as Candida albicans, Candida glabrata, and Candida tropicalis. The differentiation between species is based on unique variations in their Raman spectra, influenced by differences in cell wall composition (including beta-glucan, chitin, and mannoprotein), cell membrane components (like ergosterol), and cellular energy states (mitochondrial cytochromes b and c). This platform allows for automated molecular screening, generating diagnostic results within 2 min, making it highly practical for clinical applications. Furthermore, this technology has the potential to evaluate the effectiveness of antifungal agents, which could significantly improve patient outcomes.
引用
收藏
页码:218 / 227
页数:10
相关论文
共 70 条
  • [1] Candida auris: Information for media, U.S. Department of Health and Human Services
  • [2] Welsh R.M., Bentz M.L., Shams A., Et al., Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface, Journal of Clinical Microbiology, 55, pp. 2996-3005, (2017)
  • [3] Adams E., Quinn M., Tsay S., Et al., Candida auris in Healthcare Facilities, New York, USA, 2013–2017, Emerging Infectious Diseases, 24, pp. 1816-1824, (2018)
  • [4] Keighley C., Garnham K., Harch S.A.J., Et al., Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory, Current Fungal Infection Reports, 15, pp. 116-126, (2021)
  • [5] Hata D.J., Humphries R., Lockhart S.R., Candida auris: An Emerging Yeast Pathogen Posing Distinct Challenges for Laboratory Diagnostics, Treatment, and Infection Prevention, Archives of Pathology & Laboratory Medicine, 144, pp. 107-114, (2020)
  • [6] Borman A.M., Fraser M., Johnson E.M., CHROMagar™ Candida Plus: A Novel Chromogenic Agar That Permits the Rapid Identification of Candida auris, Medical Mycology, 59, pp. 253-258, (2020)
  • [7] de Jong A.W., Dieleman C., Carbia M., Mohd Tap R., Hagen F., Performance of Two Novel Chromogenic Media for the Identification of Multidrug-Resistant Candida auris Compared With Other Commercially Available Formulations, Journal of Clinical Microbiology, 59, (2021)
  • [8] Centers for Disease Control and Prevention, 2024, (2022)
  • [9] Ong C.W., Chen S.C.A., Clark J.E., Et al., Diagnosis, Management and Prevention of Candida auris in Hospitals: Position Statement of the Australasian Society for Infectious Diseases, Internal Medicine Journal, 49, pp. 1229-1243, (2019)
  • [10] Gade L., Munoz J., Sheth M., Et al., Understanding the Emergence of Multidrug-Resistant Candida: Using Whole-Genome Sequencing to Describe the Population Structure of Candida haemulonii Species Complex, Frontiers in Genetics, 11, (2020)